Eureka Therapeutics Stock

eurekatherapeutics.comHealthcareFounded: 2006Funding to Date: $52.37MM

Eureka Therapeutics is a biotechnology company focused on breakthrough immunotherapies for the treatment of cancer.

Register for Details

For more details on financing and valuation for Eureka Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Eureka Therapeutics.

Register Today

Team

Management Team

Cheng Liu Ph.D
Founder, President, Chief Executive Officer and Board Member
Jingyi Xiang Ph.D
Head, Bioanalytics
Yiyang Xu Ph.D
Head, Phage display
Vivien Chan Ph.D
Head, Portfolio Management

Board Members

Cheng Liu Ph.D
Hsing-Jien Kung Ph.D
Wai-Yan Chau
Bruce Ames
Peter Lee MD
Wei Zhou Ph.D
Chih-Kai Cheng
Harbinger Venture Management
Michael Cannon
Qiushi Fu
Hsing Kung Ph.D
Acorn Campus Ventures

Other companies like Eureka Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector